Search results for "Uber"

showing 10 items of 1027 documents

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia

2016

This test decreased time to treatment initiation by 66%–84%.

0301 basic medicineOncologyMaleEpidemiologylcsh:Medicine0302 clinical medicine1108 Medical MicrobiologyTuberculosis Multidrug-Resistant030212 general & internal medicinebacteriaDecreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test Latviabiologytime to treatment initiationDrug Resistance MicrobialMiddle Agedmultidrug-resistant tuberculosisRifampin resistanceInfectious Diseases1117 Public Health And Health ServicesTuberculosis Multidrug-Resistant/diagnosisFemaleRifampinLife Sciences & BiomedicineMicrobiology (medical)Adultmedicine.medical_specialtyTuberculosisAdolescentpulmonary030106 microbiologyXpert MTB/RIFImmunologyTime to treatmentMicrobiologylcsh:Infectious and parasitic diseasesTime-to-TreatmentMycobacterium tuberculosismolecular diagnostics03 medical and health sciencesYoung AdultAntibiotic resistancemultidrug resistanceInternal medicinemedicineHumanslcsh:RC109-216Multivariable modelantimicrobial resistanceTuberculin testAntibiotics AntitubercularScience & Technologybusiness.industryTuberculin TestResearchlcsh:RMycobacterium tuberculosis/drug effects1103 Clinical SciencesMycobacterium tuberculosisbiology.organism_classificationmedicine.diseaseAntibiotics Antitubercular/pharmacologyLatviatuberculosis and other mycobacteriaMultiple drug resistanceMODELTuberculin Test/methodsbusinessRifampin/pharmacologyMDR TB
researchProduct

Screening for Latent Tuberculosis Infection among Students of Healthcare Professions and Postgraduates of the Faculty of Medicine of the University o…

2017

Introduction and objective: Italy is a country with a low incidence of tuberculosis and in the last fifty years the annual number of TB cases decreased from 12,247 to 4,418, showing a reduction of approximately 64% in the number of cases and 71% in incidence. Despite of this encouraging trend, in the last years the epidemiology of tuberculosis changed and today it is a re-emerging infectious. The aim of this study is to measure the prevalence of positivity to tuberculosis infection (latent TB) in students, without any obvious manifestation of disease, attending degree courses of the health care professions and postgraduate medical courses of the School of Medicine of the University of Paler…

0301 basic medicinePediatricsmedicine.medical_specialtyTuberculosiseducation030106 microbiologyPopulationMantoux skin testQuantiFERONOccupational biohazard03 medical and health sciences0302 clinical medicineMedical and nursing students; Occupational biohazard; Quantiferon; Latent tuberculosis; Mantoux skin testMedical and nursing studentHealth careEpidemiologymedicine030212 general & internal medicineeducationeducation.field_of_studymedicine.diagnostic_testLatent tuberculosisbusiness.industrySettore MED/44 - Medicina Del LavoroMantoux testLatent tuberculosimedicine.diseaseFamily medicineObservational studybusinessQuantiferon
researchProduct

HLA-E-Restricted CD8+ T Lymphocytes Efficiently Control Mycobacterium tuberculosis and HIV-1 Co-Infection

2020

We investigated the contribution of human leukocyte antigen A2 (HLA-A2) and HLA-E-restricted CD8+ T cells in patients with Mycobacterium tuberculosis and human immunodeficiency virus 1 (HIV-1) coinfection. HIV-1 downregulates HLA-A, -B, and -C molecules in infected cells, thus influencing recognition by HLA class I-restricted CD8+ T cells but not by HLA-E-restricted CD8+ T cells, owing to the inability of the virus to downmodulate their expression. Therefore, antigen-specific HLA-E-restricted CD8+ T cells could play a protective role in Mycobacterium tuberculosis and HIV-1 coinfection. HLA-E- and HLA-A2-restricted Mycobacterium tuberculosis-specific CD8+ T cells were tested in vitro for cyt…

0301 basic medicinePulmonary and Respiratory MedicineAdultMaleTetramersTuberculosisHLA-EClinical BiochemistryT lymphocytesDown-RegulationHIV InfectionsHuman leukocyte antigenCD8-Positive T-Lymphocytes+Lymphocyte ActivationMycobacterium tuberculosis03 medical and health sciences0302 clinical medicineAntigenHLA-A2 AntigenmedicineCytotoxic T cellHumansTuberculosisLymphocyte CountMolecular BiologyAntigens BacterialbiologyCoinfectionHistocompatibility Antigens Class ICD8 T lymphocytes HLA-E Mycobacterium tuberculosis HIV tetramersCell BiologyCD8Mycobacterium tuberculosisMiddle Agedbiology.organism_classificationmedicine.diseaseVirology030104 developmental biology030228 respiratory systemCoinfectionHIV-1FemaleCD8Mycobacterium
researchProduct

Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016

2018

In Italy, rifampicin-resistant and MDR-TB were high in foreign-born persons, but decreased from 2009 to 2016

0301 basic medicinePulmonary and Respiratory MedicineExtensively Drug-Resistant TuberculosisAntitubercular AgentsEmigrants and ImmigrantsAntitubercular Agents; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Humans; Italy; Mycobacterium tuberculosis; Rifampin; Tuberculosis Multidrug-ResistantMycobacterium tuberculosis03 medical and health sciences0302 clinical medicineTuberculosis Multidrug-Resistantpolycyclic compoundsmedicineTuberculosisHumansbiologybusiness.industryExtensively drug-resistant tuberculosisMycobacterium tuberculosisMultidrug-Resistantmedicine.diseasebiology.organism_classificationVirology030104 developmental biology030228 respiratory systemItalyRifampinbusinessRifampicinmedicine.drug
researchProduct

Whole-genome sequencing for TB source investigations : principles of ethical precision public health

2021

[Background]: Whole-genome sequencing (WGS) of Mycobacterium tuberculosis allows rapid, accurate inferences about the sources, location and timing of transmission. However, in an era of heightened concern for personal privacy and science distrust, such inferences could result in unintended harm and undermine the public's trust.

0301 basic medicinePulmonary and Respiratory Medicinemedicine.medical_specialtymedia_common.quotation_subjectInternet privacyDisease OutbreaksBlame03 medical and health sciences0302 clinical medicineMedicineHumans030212 general & internal medicinehealth care economics and organizationsmedia_commonCommunity engagementDistrustWhole Genome Sequencingbusiness.industryPublic healthAdministrative PersonnelMycobacterium tuberculosisTransparency (behavior)Information sensitivity030104 developmental biologyInfectious DiseasesHarmRight to knowPublic HealthHuman medicinebusinessInternational journal of tuberculosis and lung disease
researchProduct

Yersiniaspp. in Wild Rodents and Shrews in Finland

2017

Yersinia enterocolitica and Yersinia pseudotuberculosis are important zoonotic bacteria causing human enteric yersiniosis commonly reported in Europe. All Y. pseudotuberculosis strains are considered pathogenic, while Y. enterocolitica include both pathogenic and nonpathogenic strains which can be divided into six biotypes (1A, 1B, and 2-5) and about 30 serotypes. The most common types causing yersiniosis in Europe are Y. enterocolitica bioserotypes 4/O:3 and 2/O:9. Strains belonging to biotype 1A are considered as nonpathogenic because they are missing important virulence genes like the attachment-invasion-locus (ail) gene in the chromosome and the virulence plasmid. The role of wild small…

0301 basic medicineSerotypeAIL GENEYersinia InfectionsOUTBREAKField vole030106 microbiologyVirulenceAnimals WildRodentiaYersinia413 Veterinary scienceMicrobiologyMicrobiologyRodent DiseasesYersinia kristensenii03 medical and health sciencesSpecies SpecificityVirologyINFECTIONmedicinewild small mammalsAnimalsYersinia pseudotuberculosisYersinia enterocoliticata413FinlandbiologyPSEUDOTUBERCULOSISSTRAINSShrewsta1183YersiniosisSALMONELLAbiology.organism_classificationmedicine.diseaseENVIRONMENTAL-SAMPLESVirology3142 Public health care science environmental and occupational healthYersiniazoonosesCARROTS030104 developmental biologyInfectious DiseasesENTEROCOLITICAESCHERICHIA-COLIta1181isolationVector-Borne and Zoonotic Diseases
researchProduct

Reinventing the Wheel and Making It Round Again: Evolutionary Convergence in Buchnera-Serratia Symbiotic Consortia between the Distantly Related Lach…

2016

International audience; Virtually all aphids (Aphididae) harbor Buchnera aphidicola as an obligate endosymbiont to compensate nutritional deficiencies arising from their phloem diet. Many species within the Lachninae subfamily seem to be consistently associated also with Serratia symbiotica We have previously shown that both Cinara (Cinara) cedri and Cinara (Cupressobium) tujafilina (Lachninae: Eulachnini tribe) have indeed established co-obligate associations with both Buchnera and S. symbiotica However, while Buchnera genomes of both Cinara species are similar, genome degradation differs greatly between the two S. symbiotica strains. To gain insight into the essentiality and degree of int…

0301 basic medicineSerratiaLachninaeBiodiversité et EcologieGenomeaphid endosymbiontBiodiversity and EcologyEvolution Molecular03 medical and health sciencesBuchneraPhylogeneticsRNA Ribosomal 16SBotanyGeneticsAnimalsSymbiosisPhylogenyEcology Evolution Behavior and SystematicsBuchnera aphidicola;Lachninae;Serratia symbiotica;aphid endosymbiont;co-obligate;symbiont settlementGeneticssymbiont settlementAphidbiologyObligategénomefood and beveragesbuchnera aphidicolaAphididaeSequence Analysis DNASerratia symbioticabiochemical phenomena metabolism and nutritionbiology.organism_classificationbactérie endosymbiotiqueTuberolachnus salignussymbiont030104 developmental biologypuceronAphidsCinaraévolution génomique[SDE.BE]Environmental Sciences/Biodiversity and EcologyBuchneraco-obligateGenome BacterialResearch Article
researchProduct

Search of Chemical Scaffolds for Novel Antituberculosis Agents

2005

3 A method to identify chemical scaffolds potentially active against Mycobacterium tuberculosis is presented. The molecular features of a set of structurally heterogeneous antituberculosis drugs were coded by means of structural invariants. Three tech- niques were used to obtain equations able to model the antituberculosis activity: linear discriminant analysis, multilinear re- gression, and shrinkage estimation-ridge regression. The model obtained was statistically validated through leave-n-out test, and an external set and was applied to a database for the search of new active agents. The selected compounds were assayed in vitro, and among those identified as active stand reserpine, N,N,N…

0301 basic medicineStereochemistryAntitubercular AgentsQuantitative Structure-Activity RelationshipComputational biology01 natural sciencesBiochemistryAnalytical ChemistryMycobacterium tuberculosis03 medical and health sciencesmedicineComputer SimulationMycobacterium avium complexEthambutolVirtual screeningMolecular StructurebiologyChemistrybiology.organism_classificationLinear discriminant analysis0104 chemical sciences010404 medicinal & biomolecular chemistry030104 developmental biologyModels ChemicalDrug DesignRegression AnalysisMolecular MedicineMultiple linear regression analysisBiotechnologyPentamidinemedicine.drugSLAS Discovery
researchProduct

Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei

2016

A series of dipeptide nitriles known as inhibitors of mammalian cathepsins were evaluated for inhibition of rhodesain, the cathepsin L-like protease of Trypanosoma brucei. Compound 35 consisting of a Leu residue fitting into the S2 pocket and a triarylic moiety consisting of thiophene, a 1,2,4-oxadiazole and a phenyl ring fitting into the S3 pocket, and compound 33 with a 3-bromo-Phe residue (S2) and a biphenyl fragment (S3) were found to inhibit rhodesain in the single-digit nanomolar range. The observed steep structure-activity relationship could be explained by covalent docking simulations. With their high selectivity indices (ca. 200) and the good antitrypanosomal activity (8μM) the com…

0301 basic medicineStereochemistrymedicine.medical_treatmentTrypanosoma brucei bruceiClinical BiochemistryAntitubercular AgentsPharmaceutical ScienceCysteine Proteinase InhibitorsTrypanosoma bruceiBiochemistryCysteine Proteinase InhibitorsStructure-Activity Relationship03 medical and health scienceschemistry.chemical_compoundNitrilesDrug DiscoverymedicineStructure–activity relationshipMoietyMolecular BiologyProteaseDipeptideDose-Response Relationship DrugMolecular StructurebiologyChemistryOrganic ChemistryDipeptidesbiology.organism_classificationCysteine proteaseCysteine Endopeptidases030104 developmental biologyDocking (molecular)Molecular MedicineBioorganic & Medicinal Chemistry Letters
researchProduct

Tubercle disease of sugar beet roots (Beta vulgaris) found in Poland is neither caused by Xanthomonas beticola nor by tumorigenic Agrobacterium/Rhizo…

2018

Symptoms of tubercle disease known also as Xanthomonas gall were noticed in Poland in 2014–2017. Roots with disease symptoms showed the reduction of sucrose content compared to the healthy ones. In the literature, there are two gall diseases described: tubercle disease (also known as Xanthomonas gall) and crown gall, which is caused by Rhizobium radiobacter (syn. Agrobacterium tumefaciens). None of the bacterial strains isolated from the malformed tissues were identified as the bacterial pathogen responsible for causing Xanthomonas gall or crown gall. The result was confirmed by searching for the presence of T-DNA, which was not found. Our conclusion is that the tubercle disease observed in…

0301 basic medicineTubercleAgrobacteriumPlant ScienceHorticultureRhizobium radiobacterdigestive systemMicrobiology03 medical and health sciencesfluids and secretionsTubercle diseaseXanthomonasGallPathogenbiologySugar beetdigestive oral and skin physiologyXanthomonas gallAgrobacterium tumefaciensbiology.organism_classificationdigestive system diseases030104 developmental biologyAgrobacterium tumefaciensRhizobiumSugar beetAgronomy and Crop ScienceJournal of Plant Diseases and Protection
researchProduct